Enhabit (EHAB) Stock Price, News & Analysis

Company Overview

Enhabit (NYSE:EHAB) is a leading provider of energy efficiency and home performance services in the United States. The company specializes in comprehensive solutions designed to reduce energy consumption, enhance indoor comfort and improve overall home durability. Enhabit’s offerings span from initial energy assessments and diagnostic testing to the installation of high-performance insulation, air sealing, windows and doors, as well as HVAC and water‐heating systems.

Through a network of regional service centers, Enhabit delivers tailored residential energy improvement projects for both existing homes and new construction. Its service portfolio includes blower door testing, duct sealing, attic and wall insulation, smart thermostat integration and weatherization upgrades. By combining advanced analytics with field expertise, the company helps homeowners navigate incentive programs, secure financing and achieve measurable reductions in utility costs.

Formed in 2021 through a strategic business combination, Enhabit has rapidly expanded its footprint and now operates in multiple states across the West Coast, Mountain West and Southeast regions. Headquartered in the Pacific Northwest, the company completes tens of thousands of projects annually and leverages a proprietary technology platform to track performance metrics, streamline project workflows and ensure consistent quality across its operations.

Enhabit is guided by a seasoned management team with deep experience in home services, energy consulting and operations. With executives who have held leadership roles at major service organizations and energy technology firms, the company maintains a strong focus on sustainability, customer satisfaction and continuous innovation. Enhabit’s mission is to enable homeowners to live more comfortably and sustainably while contributing to broader efforts to reduce greenhouse gas emissions.

Key Stats

• Today's Range: $6.96 to $7.38
• 50-Day Range: $7.05 to $10.80
• 52-Week Range: $6.85 to $10.91
• Volume: 782,440 shs
• Average Volume: 483,016 shs
• Market Capitalization: $357.01 million
• P/E Ratio: 29.38
• Dividend Yield: N/A
• Price Target: $8.75
• Consensus Rating: Moderate Buy

Enhabit Stock Analysis - MarketRank™

Enhabit scored higher than 47% of companies evaluated by MarketBeat, and ranked 499th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Enhabit has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Enhabit has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 31.82%

Earnings Growth

Earnings for Enhabit are expected to grow by 31.82% in the coming year, from $0.22 to $0.29 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Enhabit is 29.38, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.85.

Price to Earnings Ratio vs. Sector

The P/E ratio of Enhabit is 29.38, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.23.

Price to Book Value per Share Ratio

Enhabit has a P/B Ratio of 0.65. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.92% of the float of Enhabit has been sold short.

Short Interest Ratio / Days to Cover

Enhabit has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Enhabit has recently decreased by 4.48%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Enhabit does not currently pay a dividend.

Dividend Growth

Enhabit does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.92% of the float of Enhabit has been sold short.

Short Interest Ratio / Days to Cover

Enhabit has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Enhabit has recently decreased by 4.48%, indicating that investor sentiment is improving.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: N/A

News Sentiment

Enhabit has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Enhabit this week, compared to 2 articles on an average week.

Search Interest

1 people have searched for EHAB on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Enhabit insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 3.40% of the stock of Enhabit is held by insiders.

EHAB Stock Analysis - Frequently Asked Questions

How have EHAB shares performed this year?

Enhabit's stock was trading at $7.81 at the start of the year. Since then, EHAB shares have decreased by 9.7% and is now trading at $7.05.

How were Enhabit's earnings last quarter?

Enhabit, Inc. (NYSE:EHAB) issued its quarterly earnings results on Wednesday, May, 7th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.03. The business had revenue of $259.90 million for the quarter, compared to analysts' expectations of $266.11 million. Enhabit had a positive trailing twelve-month return on equity of 2.02% and a negative net margin of 13.43%.
Read the conference call transcript.

How do I buy shares of Enhabit?

Shares of EHAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Enhabit own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Enhabit investors own include Alphabet (GOOG), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Advanced Micro Devices (AMD), Netflix (NFLX), Home Depot (HD) and Meta Platforms (META).

Company Calendar

• Last Earnings: 5/07/2025
• Today: 7/12/2025
• Next Earnings (Estimated): 8/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NYSE:EHAB
• CIK: 1803737
• Web: www.ehab.com
• Phone: 214-239-6500
• Fax: N/A
• Employees: 10,700
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Enhabit: $8.75
• High Price Target: $9.50
• Low Price Target: $8.00
• Potential Upside/Downside: +24.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.77)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 32.05
• P/E Growth: N/A
• Net Income: -$156.20 million
• Net Margins: -13.43%
• Pretax Margin: -12.98%
• Return on Equity: 2.02%
• Return on Assets: 0.94%

Debt

• Debt-to-Equity Ratio: 0.82
• Current Ratio: 1.49
• Quick Ratio: 1.49

Sales & Book Value

• Annual Sales: $1.03 billion
• Price / Sales: 0.35
• Cash Flow: $3.90 per share
• Price / Cash Flow: 1.81
• Book Value: $10.92 per share
• Price / Book: 0.65

Miscellaneous

• Outstanding Shares: 50,640,000
• Free Float: 48,915,000
• Market Cap: $357.01 million
• Optionable: Optionable
• Beta: 1.72